Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40.

× No keyword cloud information.

112 in total

1. New insights on OX40 in the control of T cell immunity and immune tolerance in vivo.

Authors: Xiang Xiao; Weihua Gong; Gulcin Demirci; Wentao Liu; Silvia Spoerl; Xiufeng Chu; D Keith Bishop; Laurence A Turka; Xian C Li
Journal: J Immunol Date: 2011-12-05 Impact factor: 5.422

Review 2. Cell surface signaling molecules in the control of immune responses: a tide model.

Authors: Yuwen Zhu; Sheng Yao; Lieping Chen
Journal: Immunity Date: 2011-04-22 Impact factor: 31.745

Review 3. Immunotherapies for bladder cancer: a new hope.

Authors: Farhad Fakhrejahani; Yusuke Tomita; Agnes Maj-Hes; Jane B Trepel; Maria De Santis; Andrea B Apolo
Journal: Curr Opin Urol Date: 2015-11 Impact factor: 2.309

Review 4. Genetic and genomic insights into the molecular basis of atherosclerosis.

Authors: Yaoyu Chen; Jarod Rollins; Beverly Paigen; Xiaosong Wang
Journal: Cell Metab Date: 2007-09 Impact factor: 27.287

Review 5. TNF superfamily: costimulation and clinical applications.

Authors: Dass S Vinay; Byoung S Kwon
Journal: Cell Biol Int Date: 2009-02-20 Impact factor: 3.612

6. Combined targeting of costimulatory (OX40) and coinhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust antitumor immunity.

Authors: William L Redmond; Stefanie N Linch; Melissa J Kasiewicz
Journal: Cancer Immunol Res Date: 2013-11-11 Impact factor: 11.151

Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40.

1. New insights on OX40 in the control of T cell immunity and immune tolerance in vivo.

Review 2. Cell surface signaling molecules in the control of immune responses: a tide model.

Review 3. Immunotherapies for bladder cancer: a new hope.

Review 4. Genetic and genomic insights into the molecular basis of atherosclerosis.

Review 5. TNF superfamily: costimulation and clinical applications.

6. Combined targeting of costimulatory (OX40) and coinhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust antitumor immunity.

7. OX40 costimulation turns off Foxp3+ Tregs.

8. Effects of OX40-OX40L interaction on the nuclear factor of activated T cells c1 in ApoE-deficient mice.

9. TNF superfamily receptor OX40 triggers invariant NKT cell pyroptosis and liver injury.

10. Anaphylaxis caused by repetitive doses of a GITR agonist monoclonal antibody in mice.